{"name":"Pfizer Venture Investments","permalink":"pfizer-venture-investments","crunchbase_url":"http://www.crunchbase.com/financial-organization/pfizer-venture-investments","homepage_url":"http://www.pfizer.com/research/licensing/venture_investments.jsp","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"","description":"","email_address":"","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Mon Jun 15 16:12:57 UTC 2009","updated_at":"Tue Aug 04 00:00:07 UTC 2009","overview":"<p>Pfizer Venture Investments (PVI) serves as the venture capital arm of Pfizer, supporting a variety of worldwide business development (WWBD) activities. Using Pfizer capital, they invest in innovative healthcare businesses offering new technology platforms that align with their company&#8217;s strategic direction. They actively support companiesâ€”both financially and as board representativesâ€”as appropriate.</p>","image":null,"offices":[],"relationships":[],"investments":[{"funding_round":{"round_code":"d","source_url":"http://www.avidrp.com/press_releases/05-21-09_Avid_Series_D.pdf","source_description":"Avid Radiopharmaceuticals Closes $34.5 Million Series D Financing","raised_amount":34500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":5,"funded_day":21,"company":{"name":"Avid Radiopharmaceuticals","permalink":"avid-radiopharmaceuticals","image":{"available_sizes":[[[150,50],"assets/images/resized/0004/8595/48595v2-max-150x150.png"],[[213,72],"assets/images/resized/0004/8595/48595v2-max-250x250.png"],[[213,72],"assets/images/resized/0004/8595/48595v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://equityhelpdesk.com/node/3920","source_description":"HD Biosciences Raises First Round","raised_amount":null,"raised_currency_code":"USD","funded_year":2008,"funded_month":8,"funded_day":8,"company":{"name":"HD Biosciences","permalink":"hd-biosciences","image":{"available_sizes":[[[150,63],"assets/images/resized/0005/0450/50450v1-max-150x150.jpg"],[[250,106],"assets/images/resized/0005/0450/50450v1-max-250x250.jpg"],[[298,127],"assets/images/resized/0005/0450/50450v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2010/01/flexion-therapeutics-closes-42m-series.html","source_description":"Flexion Therapeutics Closes $42M Series A Funding and Three in-licensing Deals","raised_amount":42000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":29,"company":{"name":"Flexion Therapeutics","permalink":"flexion-therapeutics","image":{"available_sizes":[[[140,56],"assets/images/resized/0006/3158/63158v1-max-150x150.png"],[[140,56],"assets/images/resized/0006/3158/63158v1-max-250x250.png"],[[140,56],"assets/images/resized/0006/3158/63158v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.fiercebiotech.com/story/nodality-gains-backing-pfizer-ventures-15-5m-round/2010-03-22?utm_medium=rss&utm_source=rss","source_description":"Nodality gains backing from Pfizer Ventures in $15.5M round  Read more: http://www.fiercebiotech.com/story/nodality-gains-backing-pfizer-ventures-15-5m-round/2010-03-22?utm_medium=rss&utm_source=rss#ixzz0ixGe93nH","raised_amount":2000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":22,"company":{"name":"Nodality","permalink":"nodality","image":{"available_sizes":[[[150,36],"assets/images/resized/0007/3510/73510v1-max-150x150.jpg"],[[250,60],"assets/images/resized/0007/3510/73510v1-max-250x250.jpg"],[[263,64],"assets/images/resized/0007/3510/73510v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/ablexis-llc-series-a-12m/","source_description":"Ablexis, LLC: Series A $12M","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":4,"company":{"name":"Ablexis","permalink":"ablexis","image":{"available_sizes":[[[150,30],"assets/images/resized/0008/9828/89828v1-max-150x150.jpg"],[[223,46],"assets/images/resized/0008/9828/89828v1-max-250x250.jpg"],[[223,46],"assets/images/resized/0008/9828/89828v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.aqxpharma.com/news/news-20100617.html","source_description":"Aquinox Pharmaceuticals completes US $25 million Series B financing","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":17,"company":{"name":"Aquinox Pharmaceuticals","permalink":"aquinox-pharmaceuticals","image":{"available_sizes":[[[150,56],"assets/images/resized/0009/1000/91000v1-max-150x150.jpg"],[[200,75],"assets/images/resized/0009/1000/91000v1-max-250x250.jpg"],[[200,75],"assets/images/resized/0009/1000/91000v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32&aid=DJFVW00020100928e69s00001&r=Rss&s=DJFVW","source_description":"TetraLogic Pharma Boosts Series C To $37M With Pfizer Ventures Capital  ","raised_amount":5000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":27,"company":{"name":"TetraLogic Pharmaceuticals","permalink":"tetralogic-pharmaceuticals","image":{"available_sizes":[[[150,43],"assets/images/resized/0009/8561/98561v1-max-150x150.png"],[[250,72],"assets/images/resized/0009/8561/98561v1-max-250x250.png"],[[270,78],"assets/images/resized/0009/8561/98561v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://www.marketwire.com/press-release/neuronetics-inc-raises-30-million-in-series-e-financing-1514679.htm","source_description":"Neuronetics, Inc. Raises $30 Million in Series E Financing","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":5,"funded_day":16,"company":{"name":"Neuronetics","permalink":"neuronetics","image":{"available_sizes":[[[150,24],"assets/images/resized/0006/3974/63974v1-max-150x150.jpg"],[[250,40],"assets/images/resized/0006/3974/63974v1-max-250x250.jpg"],[[286,46],"assets/images/resized/0006/3974/63974v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/07/dvs-sciences-completes-14-6m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"DVS Sciences Completes $14.6M Series A Financing","raised_amount":14600000,"raised_currency_code":"USD","funded_year":2011,"funded_month":7,"funded_day":14,"company":{"name":"DVS Sciences","permalink":"dvs-sciences","image":{"available_sizes":[[[150,27],"assets/images/resized/0014/4332/144332v1-max-150x150.png"],[[226,41],"assets/images/resized/0014/4332/144332v1-max-250x250.png"],[[226,41],"assets/images/resized/0014/4332/144332v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2012/02/celladon-closes-43m-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Celladon Closes $43M in Funding","raised_amount":43000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":2,"funded_day":15,"company":{"name":"Celladon","permalink":"celladon","image":{"available_sizes":[[[150,19],"assets/images/resized/0006/4625/64625v1-max-150x150.jpg"],[[250,33],"assets/images/resized/0006/4625/64625v1-max-250x250.jpg"],[[338,45],"assets/images/resized/0006/4625/64625v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2012/07/mersana-therapeutics-raises-27m-series-a-1-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Mersana Therapeutics Raises $27M in Series A-1 Financing","raised_amount":27000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":7,"funded_day":31,"company":{"name":"Mersana Therapeutics","permalink":"mersana-therapeutics","image":{"available_sizes":[[[150,60],"assets/images/resized/0009/2309/92309v1-max-150x150.jpg"],[[195,78],"assets/images/resized/0009/2309/92309v1-max-250x250.jpg"],[[195,78],"assets/images/resized/0009/2309/92309v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2012/10/mirna-therapeutics-completes-34-5m-series-financing.html","source_description":"Mirna Therapeutics Completes $34.5M Series C Financing","raised_amount":34500000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":24,"company":{"name":"Mirna Therapeutics","permalink":"mirna-therapeutics","image":{"available_sizes":[[[150,34],"assets/images/resized/0007/0130/70130v1-max-150x150.jpg"],[[250,58],"assets/images/resized/0007/0130/70130v1-max-250x250.jpg"],[[254,59],"assets/images/resized/0007/0130/70130v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.marketwatch.com/story/ziarco-founded-with-series-a-financing-to-develop-first-in-class-anti-inflammatory-and-anti-allergic-medicines-2012-11-05","source_description":"Ziarco Founded with Series A Financing to Develop First-in Class Anti-inflammatory and Anti-allergic Medicines","raised_amount":6000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":11,"funded_day":5,"company":{"name":"Ziarco Pharma","permalink":"ziarco-pharma","image":{"available_sizes":[[[150,52],"assets/images/resized/0021/8782/218782v1-max-150x150.jpg"],[[250,88],"assets/images/resized/0021/8782/218782v1-max-250x250.jpg"],[[281,99],"assets/images/resized/0021/8782/218782v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2012/11/epic-sciences-completes-13m-series-equity-financing.html","source_description":"Epic Sciences Completes $13M Series B Equity Financing","raised_amount":13000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":11,"funded_day":13,"company":{"name":"Epic Sciences","permalink":"epic-sciences","image":{"available_sizes":[[[150,31],"assets/images/resized/0022/0799/220799v1-max-150x150.jpg"],[[250,52],"assets/images/resized/0022/0799/220799v1-max-250x250.jpg"],[[335,70],"assets/images/resized/0022/0799/220799v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.pehub.com/174484/rhythm-adds-8m-cap-series-b-33m/","source_description":"Rhythm Adds $8M to Cap Series B at $33M","raised_amount":8000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":11,"funded_day":27,"company":{"name":"Rhythm Pharmaceuticals","permalink":"rhythm-pharmaceuticals","image":{"available_sizes":[[[150,70],"assets/images/resized/0008/0469/80469v10-max-150x150.jpg"],[[168,79],"assets/images/resized/0008/0469/80469v10-max-250x250.jpg"],[[168,79],"assets/images/resized/0008/0469/80469v10-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.reuters.com/article/2012/12/04/idUS44157+04-Dec-2012+PRN20121204","source_description":"Flexion Therapeutics Secures $20 Million in Series B Financing","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":12,"funded_day":4,"company":{"name":"Flexion Therapeutics","permalink":"flexion-therapeutics","image":{"available_sizes":[[[140,56],"assets/images/resized/0006/3158/63158v1-max-150x150.png"],[[140,56],"assets/images/resized/0006/3158/63158v1-max-250x250.png"],[[140,56],"assets/images/resized/0006/3158/63158v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}